OSR Holdings shares surge 14.62% after-hours after Nasdaq grants 180-day extension to meet $1 bid price, advancing VXM01 licensing and device merger.

OSR Holdings Inc. surged 14.62% in after-hours trading following the announcement that it received a 180-day Nasdaq extension to regain compliance with the $1.00 bid price requirement, extending the deadline to August 31, 2026. The company reaffirmed its focus on strategic initiatives, including a potential $30 million upfront, $815 million milestone VXM01 licensing deal and a merger of its medical device platforms. Management emphasized that the extension provides operational runway to execute these value drivers and strengthen capital structure, addressing prior concerns about trading dynamics. The extension, combined with progress on high-impact transactions, alleviated near-term delisting risks and signaled confidence in long-term value creation, driving the significant after-hours rally.